These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 22446020)
41. The use of COLD-PCR and high-resolution melting analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer. Mancini I; Santucci C; Sestini R; Simi L; Pratesi N; Cianchi F; Valanzano R; Pinzani P; Orlando C J Mol Diagn; 2010 Sep; 12(5):705-11. PubMed ID: 20616366 [TBL] [Abstract][Full Text] [Related]
42. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection. Ibrahem S; Seth R; O'Sullivan B; Fadhil W; Taniere P; Ilyas M Int J Exp Pathol; 2010 Dec; 91(6):500-5. PubMed ID: 21199003 [TBL] [Abstract][Full Text] [Related]
43. [Detection of KRAS,NRAS and BRAF gene mutations in colorectal carcinoma]. Zhang K; Xu J; Yan L; Liu X; Xu F; Liu Y Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):254-7. PubMed ID: 25975908 [TBL] [Abstract][Full Text] [Related]
44. KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab. Stremitzer S; Stift J; Gruenberger B; Tamandl D; Aschacher T; Wolf B; Wrba F; Gruenberger T Br J Surg; 2012 Nov; 99(11):1575-82. PubMed ID: 23027075 [TBL] [Abstract][Full Text] [Related]
45. KRAS mutation analysis by PCR: a comparison of two methods. Bolton L; Reiman A; Lucas K; Timms J; Cree IA PLoS One; 2015; 10(1):e0115672. PubMed ID: 25568935 [TBL] [Abstract][Full Text] [Related]
46. The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer. Fadhil W; Ibrahem S; Seth R; AbuAli G; Ragunath K; Kaye P; Ilyas M Histopathology; 2012 Dec; 61(6):1117-24. PubMed ID: 22882224 [TBL] [Abstract][Full Text] [Related]
47. A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction. Suzuki S; Matsusaka S; Hirai M; Shibata H; Takagi K; Mizunuma N; Hatake K Int J Oncol; 2015 Jul; 47(1):97-105. PubMed ID: 25936694 [TBL] [Abstract][Full Text] [Related]
48. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR. Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035 [TBL] [Abstract][Full Text] [Related]
49. BRAF and KRAS mutations in prostatic adenocarcinoma. Cho NY; Choi M; Kim BH; Cho YM; Moon KC; Kang GH Int J Cancer; 2006 Oct; 119(8):1858-62. PubMed ID: 16721785 [TBL] [Abstract][Full Text] [Related]
50. A multiplex technology platform for the rapid analysis of clinically actionable genetic alterations and validation for BRAF p.V600E detection in 1549 cytologic and histologic specimens. Smith DL; Lamy A; Beaudenon-Huibregtse S; Sesboüé R; Laosinchai-Wolf W; Sabourin JC; Labourier E Arch Pathol Lab Med; 2014 Mar; 138(3):371-8. PubMed ID: 23808402 [TBL] [Abstract][Full Text] [Related]
51. Detection of BRAF mutations in colorectal tumours and peritoneal washings using a mismatch ligation assay. Busby K; Morris A J Clin Pathol; 2005 Apr; 58(4):372-5. PubMed ID: 15790700 [TBL] [Abstract][Full Text] [Related]
52. ARMS-PCR for detection of BRAF V600E hotspot mutation in comparison with Real-Time PCR-based techniques. Machnicki MM; Glodkowska-Mrowka E; Lewandowski T; Ploski R; Wlodarski P; Stoklosa T Acta Biochim Pol; 2013; 60(1):57-64. PubMed ID: 23460942 [TBL] [Abstract][Full Text] [Related]
53. Clinical Validation of a Multiplex Kit for RAS Mutations in Colorectal Cancer: Results of the RASKET (RAS KEy Testing) Prospective, Multicenter Study. Yoshino T; Muro K; Yamaguchi K; Nishina T; Denda T; Kudo T; Okamoto W; Taniguchi H; Akagi K; Kajiwara T; Hironaka S; Satoh T EBioMedicine; 2015 Apr; 2(4):317-23. PubMed ID: 26137573 [TBL] [Abstract][Full Text] [Related]
55. [Clinical-pathological features and gene profile in colorectal cancer]. Perazzo F; Piaggio F; Krupitzki H; García A; Avagnina A; Elsner B; Denninghoff V Medicina (B Aires); 2013; 73(5):417-22. PubMed ID: 24152396 [TBL] [Abstract][Full Text] [Related]
56. Automated PCR detection of BRAF mutations in colorectal adenocarcinoma: a diagnostic test accuracy study. Colling R; Wang LM; Soilleux E J Clin Pathol; 2016 May; 69(5):398-402. PubMed ID: 26537294 [TBL] [Abstract][Full Text] [Related]
57. EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix. Dimmler A; Geddert H; Faller G Pathol Res Pract; 2014 May; 210(5):274-8. PubMed ID: 24560515 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors. Pichler M; Balic M; Stadelmeyer E; Ausch C; Wild M; Guelly C; Bauernhofer T; Samonigg H; Hoefler G; Dandachi N J Mol Diagn; 2009 Mar; 11(2):140-7. PubMed ID: 19213871 [TBL] [Abstract][Full Text] [Related]
59. Comparison of KRAS mutation status between primary tumor and metastasis in Chinese colorectal cancer patients. Li ZZ; Bai L; Wang F; Zhang ZC; Wang F; Zeng ZL; Zeng JB; Zhang DS; Wang FH; Wang ZQ; Li YH; Shao JY; Xu RH Med Oncol; 2016 Jul; 33(7):71. PubMed ID: 27270901 [TBL] [Abstract][Full Text] [Related]
60. Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of Galanopoulos M; Papanikolaou IS; Zografos E; Viazis N; Papatheodoridis G; Karamanolis D; Marinos E; Mantzaris GJ; Gazouli M Anticancer Res; 2017 Feb; 37(2):651-657. PubMed ID: 28179313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]